Summit Investment Advisors »

Sagimet Biosciences Inc-a shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.8k 525 5.42
2023-12-31 $2.8k 525 5.42
2023-09-30 $4.6k 525 8.80

More positions owned by Summit Investment Advisors

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Ishares Tr Etf (IVV)
Vanguard Europe Pacific ETF (VEA)
Vanguard S&p 500 Etf idx (VOO)
iShares Lehman Aggregate Bond (AGG)
Spdr Ser Tr Etf (ONEV)
Alphabet Inc Class C cs (GOOG)
Facebook Inc cl a (META)
Broadcom (AVGO)
iShares S&P 500 Growth Index (IVW)
Vanguard Total Bond Market ETF (BND)
iShares S&P 500 Value Index (IVE)

View all positions for Summit Investment Advisors

Top funds holding Sagimet Biosciences Inc-a

Point72 Asset Management
BlackRock
NEA Management Company
Blue Owl Capital Holdings
Hillhouse Capital Advisors
Baker Bros. Advisors
Vanguard Group
Jpmorgan Chase & Co
Alyeska Investment Group
Rock Springs Capital Management
Artal Group
Partner Fund Management
Millennium Management
Ikarian Capital
Geode Capital Management

View all funds holding Sagimet Biosciences Inc-a